Published in Gene Therapy Weekly, February 20th, 1995
David A. Williams and Thomas Moritz, Indiana University School of Medicine, Indianapolis, stated that they identified a chymotryptic fragment of the extracellular matrix molecule fibronectin (FN 30/35), to which primitive hematopoietic cells adhere. The researchers stated that their findings suggest that the use of the FN 30/35 fibronectin molecule may offer a clinically applicable protocol to achieve efficient gene delivery to the human hematopoietic system ("Umbilical Cord Blood Stem Cells as Targets for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.